Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
André Willasch(Goethe University Frankfurt), Adriana Balduzzi(Azienda Ospedaliera San Gerardo), Rose‐Marie Hamladji(Centre de Recherche Nucléaire d’Alger), Herbert Pichler(St Anna Children's Hospital), Jean‐Hugues Dalle(Inserm), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Olga Aleinikova(Stichting Kinderoncologie Nederland), António Campos(Instituto Português de Oncologia Francisco Gentil), Franco Locatelli(Bambino Gesù Children's Hospital), Ain Kaare(Tartu University Hospital), Alicja Chybicka, Stephen Robinson(Intel (United States)), Boris V. Afanasyev(First Pavlov State Medical University of St. Petersburg), Reuven Or(Hadassah Academic College), Jelena Rascon(Vilnius University), Arnaud Dalissier(Inserm), Gergely Kriván(National Center for Epidemiology), Jochen Buechner(Oslo University Hospital), Manuel Abecasis(IPO Porto), Myriam Labopin(Sorbonne Université), Е. В. Скоробогатова(Russian Children's Clinical Hospital), Vassiliki Kitra‐Roussou(Children's Hospital Agia Sophia), Amir Ali Hamidieh(Stem Cell Technology Research Center), Alphan Küpesiz(Akdeniz University), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Paul Veys(Great Ormond Street Hospital), Arcangelo Prete(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Jacek Wachowiak(Poznan University of Medical Sciences), Arjan C. Lankester(Leiden University Medical Center), Amal Al-Seraihy(King Faisal Specialist Hospital & Research Centre), Franca Fagioli(Ospedale Regina Margherita), Marianne Ifversen(Copenhagen University Hospital), Sabina Sufliarska(Comenius University Bratislava), Alice Bertaina(Stanford University), Selim Corbacioglu(Unknown), Marc Ansari(University of Geneva), Kálmán Nagy, Kim Vettenranta(Universität Hamburg), Marc Bierings(University Medical Center Utrecht), Jan Styczyński(Nicolaus Copernicus University), Ardeshir Ghavamzadeh(Tehran University of Medical Sciences), Sophie Dupont(University of Mons), Gérard Michel(Hôpital d'Enfants), Petr Sedláček(University Hospital in Motol), Yves Bertrand(Université Claude Bernard Lyon 1), Tayfun Güngör, Damir Nemet(University Hospital Centre Zagreb), Thomas Klingebiel(Goethe University Frankfurt), Akif Yeşilipek(Bahçeşehir University), Mikael Sundin(Karolinska University Hospital)
Cited by 61
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0
|Nature Protocols|2019|1.4k